Abstract
In 2006, the global interventional cardiology device market-including revenues
generated in the US, Europe (France, Germany, Italy, and the UK), and
Japan-was valued at over $6.0 billion.
Market revenues comprise sales of coronary stents, percutaneous transluminal
coronary angioplasty balloon catheters, IC accessory devices, and embolic
protection devices